These results suggest that upstream therapy targeting CaMKII and TGF-β1 as well as reducing oxidative stress is a potentially effective strategy for preventing AF caused by a diet high in fat, sugar, and cholesterol. This evidence concerns the gene TGFB1 and atrial fibrillation.